e.g. mhealth
Search Results (1 to 3 of 3 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Cancer
- 1 JMIR Formative Research
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

Although providing flexibility and convenience, contacting prospective participants through telephone, email, and mail without face-to-face meetings could jeopardize participant accrual and retention, because cold-calling and remote contacts reduced trust. The sensitive nature of prostate cancer could exacerbate these concerns for patients and partners.
J Med Internet Res 2024;26:e51877
Download Citation: END BibTex RIS

NCTN trials are critical to advancing cancer care, but many trials take years to complete accrual owing to lower-than-projected accrual rates.
To facilitate the goal of meeting projected clinical trial accrual, the NRG Oncology Protocol Operations Management (POM) Committee sought to develop, with input from the NRG Communications Committee, a tool kit for study principal investigators of newly activated NRG Oncology trials.
JMIR Cancer 2022;8(3):e38514
Download Citation: END BibTex RIS

Haidich et al [16] proposed that a Gini coefficient for accrual distribution in multisite trials could provide a standardized approach to assessing accrual disparities. They identified a Gini coefficient of less than 0.2 as suggesting low accrual inequality and calculated a mean Gini coefficient of 0.33 among multisite trials.
The KUMC granted approval under a central institutional review board with reliance by the other institutions (STUDY00003455).
JMIR Form Res 2021;5(12):e30368
Download Citation: END BibTex RIS